What is BioHarvest Sciences?
BioHarvest Sciences is at the forefront of developing and commercializing an industrial-scale plant cell technology platform. This innovative approach is designed for the efficient production of plant metabolites, offering a novel pathway for various applications. The company's focus on advanced biotechnology positions it within a rapidly evolving sector.
How much funding has BioHarvest Sciences raised?
BioHarvest Sciences has raised a total of $796K across 2 funding rounds:
Private Equity
$402K
Other Financing Round
$394K
Private Equity (2025): $402K, investors not publicly disclosed
Other Financing Round (2025): $394K, investors not publicly disclosed
What's next for BioHarvest Sciences?
The recent major strategic investment signals a pivotal phase for BioHarvest Sciences, likely enabling accelerated scaling of its production capabilities and further research and development into its plant metabolite offerings. This capital infusion is expected to bolster its market position and support expansion into new territories or product lines, leveraging its proprietary technology for sustained growth.
See full BioHarvest Sciences company page
